BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 23800669)

  • 1. Impact of the interval between short-course radiotherapy and surgery on outcomes of rectal cancer patients.
    van den Broek CB; Vermeer TA; Bastiaannet E; Rutten HJ; van de Velde CJ; Marijnen CA
    Eur J Cancer; 2013 Oct; 49(15):3131-9. PubMed ID: 23800669
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impact of the introduction and training of total mesorectal excision on recurrence and survival in rectal cancer in The Netherlands.
    Kapiteijn E; Putter H; van de Velde CJ;
    Br J Surg; 2002 Sep; 89(9):1142-9. PubMed ID: 12190680
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The TME trial after a median follow-up of 6 years: increased local control but no survival benefit in irradiated patients with resectable rectal carcinoma.
    Peeters KC; Marijnen CA; Nagtegaal ID; Kranenbarg EK; Putter H; Wiggers T; Rutten H; Pahlman L; Glimelius B; Leer JW; van de Velde CJ;
    Ann Surg; 2007 Nov; 246(5):693-701. PubMed ID: 17968156
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Quality assurance in rectal cancer treatment.
    van de Velde CJ; van den Broek CB
    Dig Dis; 2012; 30 Suppl 2():126-31. PubMed ID: 23207944
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Benefits and drawbacks of short-course preoperative radiotherapy in rectal cancer patients aged 75 years and older.
    Maas HA; Lemmens VE; Nijhuis PH; de Hingh IH; Koning CC; Janssen-Heijnen ML
    Eur J Surg Oncol; 2013 Oct; 39(10):1087-93. PubMed ID: 23958151
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cost-utility analysis of preoperative radiotherapy in patients with rectal cancer undergoing total mesorectal excision: a study of the Dutch Colorectal Cancer Group.
    Van Den Brink M; Van Den Hout WB; Stiggelbout AM; Klein Kranenbarg E; Marijnen CA; Van De Velde CJ; Kievit J;
    J Clin Oncol; 2004 Jan; 22(2):244-53. PubMed ID: 14665610
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An interval >7 weeks between neoadjuvant therapy and surgery improves pathologic complete response and disease-free survival in patients with locally advanced rectal cancer.
    Tulchinsky H; Shmueli E; Figer A; Klausner JM; Rabau M
    Ann Surg Oncol; 2008 Oct; 15(10):2661-7. PubMed ID: 18389322
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Total mesorectal excision (TME) with or without preoperative radiotherapy in the treatment of primary rectal cancer. Prospective randomised trial with standard operative and histopathological techniques. Dutch ColoRectal Cancer Group.
    Kapiteijn E; Kranenbarg EK; Steup WH; Taat CW; Rutten HJ; Wiggers T; van Krieken JH; Hermans J; Leer JW; van de Velde CJ
    Eur J Surg; 1999 May; 165(5):410-20. PubMed ID: 10391155
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Survival of elderly rectal cancer patients not improved: analysis of population based data on the impact of TME surgery.
    Rutten H; den Dulk M; Lemmens V; Nieuwenhuijzen G; Krijnen P; Jansen-Landheer M; van de Poll Franse L; Coebergh JW; Martijn H; Marijnen C; van de Velde C
    Eur J Cancer; 2007 Oct; 43(15):2295-300. PubMed ID: 17709242
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Late side effects of short-course preoperative radiotherapy combined with total mesorectal excision for rectal cancer: increased bowel dysfunction in irradiated patients--a Dutch colorectal cancer group study.
    Peeters KC; van de Velde CJ; Leer JW; Martijn H; Junggeburt JM; Kranenbarg EK; Steup WH; Wiggers T; Rutten HJ; Marijnen CA
    J Clin Oncol; 2005 Sep; 23(25):6199-206. PubMed ID: 16135487
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intermediate-fraction neoadjuvant radiotherapy for rectal cancer.
    Zhan T; Gu J; Li M; Du C
    Dis Colon Rectum; 2013 Apr; 56(4):422-32. PubMed ID: 23478609
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Factors that influence the adequacy of total mesorectal excision for rectal cancer.
    Jeyarajah S; Sutton CD; Miller AS; Hemingway D;
    Colorectal Dis; 2007 Nov; 9(9):808-15. PubMed ID: 17441969
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efforts to improve local control in rectal cancer compromise survival by the potential morbidity of optimal mesorectal excision.
    Laurent C; Nobili S; Rullier A; Vendrely V; Saric J; Rullier E
    J Am Coll Surg; 2006 Nov; 203(5):684-91. PubMed ID: 17084330
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Preoperative hyperfractionated chemoradiation for locally recurrent rectal cancer in patients previously irradiated to the pelvis: A multicentric phase II study.
    Valentini V; Morganti AG; Gambacorta MA; Mohiuddin M; Doglietto GB; Coco C; De Paoli A; Rossi C; Di Russo A; Valvo F; Bolzicco G; Dalla Palma M;
    Int J Radiat Oncol Biol Phys; 2006 Mar; 64(4):1129-39. PubMed ID: 16414206
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A short course of preoperative radiotherapy improves prognosis of operable rectal carcinoma: a case control study.
    Penopoulos V; Handolias M; Avgerinos A; Maris T; Ilias T; Issopoulos N; Christianopoulos G; Betsis D; Vrettou E; Kitis G; Pistevou K
    Hepatogastroenterology; 2008; 55(85):1280-7. PubMed ID: 18795673
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Radical surgery and postoperative radiotherapy as combined treatment in rectal cancer. Final results of a phase III study of the European Organization for Research and Treatment of Cancer.
    Arnaud JP; Nordlinger B; Bosset JF; Boes GH; Sahmoud T; Schlag PM; Pene F
    Br J Surg; 1997 Mar; 84(3):352-7. PubMed ID: 9117306
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Local tumor control and (disease-free) survival after surgery with pre- and intraoperative radiotherapy for primary non-resectable rectal carcinoma and local recurrence].
    Mannaerts GH; Martijn H; Rutten HJ; Hanssens PE; Wiggers T
    Ned Tijdschr Geneeskd; 2001 Jul; 145(30):1460-6. PubMed ID: 11503316
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Short-term outcome after neoadjuvant high-dose-rate endorectal brachytherapy or short-course external beam radiotherapy in resectable rectal cancer.
    Hesselager C; Vuong T; PĂ„hlman L; Richard C; Liberman S; Letellier F; Folkesson J
    Colorectal Dis; 2013 Jun; 15(6):662-6. PubMed ID: 23461819
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Local recurrence and survival rate after rectal cancer operations and multimodal therapy].
    Thomschke D; Kyau-Ummen B; Halbfass HJ
    Chirurg; 2002 Mar; 73(3):245-54. PubMed ID: 11963499
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Health-related quality of life 14 years after preoperative short-term radiotherapy and total mesorectal excision for rectal cancer: report of a multicenter randomised trial.
    Wiltink LM; Chen TY; Nout RA; Kranenbarg EM; Fiocco M; Laurberg S; van de Velde CJ; Marijnen CA
    Eur J Cancer; 2014 Sep; 50(14):2390-8. PubMed ID: 25060825
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.